Clinical Roundup VHIO’s novel CAR T-cell therapy demonstrates efficacy and safety in preclinical models of HER2-positive solid tumors November 22, 2024Vol.50 No.44
Clinical Roundup Hemokine modulatory regimen shows promise for TNBC in phase I study November 22, 2024Vol.50 No.44
Clinical Roundup Fralin Biomedical Research Institute spinoff company focuses on peptide drugs targeting cancer stem cells November 22, 2024Vol.50 No.44
Clinical Roundup Data from Gardasil 9 studies reinforce importance of gender-neutral HPV vaccination in adults November 15, 2024Vol.50 No.43
Clinical Roundup Only half of young patients with cancer report a discussion on fertility preservation November 15, 2024Vol.50 No.43
Clinical Roundup Combination immunotherapy + chemo is safe and effective for advanced small cell cancers in bladder and prostate November 15, 2024Vol.50 No.43
Clinical Roundup SU2C, Johnson & Johnson collaborate on research project focused on rare disease linked to blood cancers November 15, 2024Vol.50 No.43
Clinical Roundup Stanford Medicine-led team uncovers potential therapy based on extrachromosomal DNA research November 15, 2024Vol.50 No.43
Clinical Roundup Phase I clinical trial of Keytruda + Lymphir for recurrent solid tumors yields positive preliminary results November 15, 2024Vol.50 No.43
